Related Experiment Videos
Transient ischemic attacks and ischemic stroke: indications for anticoagulation
1Department of Neurology, Northwestern University Medical School, Chicago, Illinois.
Insights
Anticoagulant therapy is used for selected cerebrovascular disease patients to prevent recurrent strokes and manage ongoing events. Careful patient selection and ruling out contraindications are essential for effective use.
Area of Science:
- Neurology
- Cardiology
- Vascular Medicine
Background:
- The efficacy of anticoagulant therapy in cerebrovascular disease lacks robust documentation.
- Current clinical practice relies on limited evidence, including personal experience and uncontrolled studies.
Purpose of the Study:
- To outline the current indications for anticoagulant use in cerebrovascular disease.
- To emphasize the importance of careful patient selection and contraindication assessment.
Main Methods:
- Review of current practices and indications for anticoagulant therapy in cerebrovascular disease.
- Discussion of patient selection criteria for specific stroke types.
Main Results:
- Anticoagulants are utilized in specific scenarios: preventing recurrent cardioembolic stroke, managing progressive atherothrombotic stroke, and preventing stroke after transient ischemic attacks.
- The study highlights the need for thorough evaluation before administration.
Conclusions:
- Anticoagulant therapy has a role in managing selected cerebrovascular events.
- Physicians must carefully assess patients for contraindications and non-thrombotic causes of deterioration before initiating anticoagulation.
Abstract:
The value of anticoagulant therapy in cerebrovascular disease has not been adequately documented. Until the results of well-designed trials are available, physicians must use these agents on the basis of personal experience, anecdotal reports, and uncontrolled series. We use anticoagulants in selected patients to (1) prevent recurrent cardioembolic stroke, (2) stem the progression of atherothrombotic stroke in progress, and (3) prevent stroke in patients presenting with a series of transient ischemic attacks. Given the improved status of anticoagulants in cerebrovascular disease, it is essential to rule out contraindications or nonthrombotic causes of patient deterioration before they are administered.